DrugPatentWatch Database Preview

Par Pharm Company Profile

PAR PHARM has two hundred and sixteen approved drugs.

There is one US patent protecting PAR PHARM drugs. There are fourteen tentative approvals on PAR PHARM drugs.

There are nine patent family members on PAR PHARM drugs in eight countries and one hundred and sixteen supplementary protection certificates in twelve countries.

International Patents:	9
US Patents:	1
Tradenames:	130
Ingredients:	127
NDAs:	216
Patent Litigation for Par Pharm:	See patent lawsuits for Par Pharm
PTAB Cases with Par Pharm as petitioner:	See PTAB cases with Par Pharm as petitioner

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Pharm	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	CAPSULE;ORAL	076922-003	Dec 16, 2004	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Par Pharm	METHYLPREDNISOLONE	methylprednisolone	TABLET;ORAL	089209-001	Apr 25, 1988		DISCN	No	No		➤ Sign Up				➤ Sign Up
Par Pharm	DOXYCYCLINE	doxycycline	TABLET;ORAL	065070-003	Dec 30, 2002	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Par Pharm	MEGESTROL ACETATE	megestrol acetate	TABLET;ORAL	072422-001	Aug 8, 1988	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Par Pharm Inc	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	4,859,692	➤ Sign Up
Par Pharm	CAPOTEN	captopril	TABLET;ORAL	018343-003	Approved Prior to Jan 1, 1982	5,238,924	➤ Sign Up
Par Pharm	CAPOTEN	captopril	TABLET;ORAL	018343-004	Jun 13, 1995	5,238,924	➤ Sign Up
Par Pharm	NASCOBAL	cyanocobalamin	GEL, METERED;NASAL	019722-001	Nov 5, 1996	4,724,231	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Nasal Spray	500 mcg/spray	➤ Subscribe	2017-04-28
➤ Subscribe	Tablets	10 mg and 20 mg	➤ Subscribe	2008-02-29

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
European Patent Office	1948613	➤ Sign Up
South Korea	20080000660	➤ Sign Up
Australia	2006240490	➤ Sign Up
World Intellectual Property Organization (WIPO)	2006115626	➤ Sign Up
Country	Document Number	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C/GB98/040	United Kingdom	➤ Sign Up	PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508
C/GB11/015	United Kingdom	➤ Sign Up	PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
2014000024	Germany	➤ Sign Up	PRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
2014029	Lithuania	➤ Sign Up	PRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.